GABAB2 is essential for G-protein coupling of the GABAB receptor heterodimer

被引:166
作者
Robbins, MJ
Calver, AR
Filippov, AK
Hirst, WD
Russell, RB
Wood, MD
Nasir, S
Couve, A
Brown, DA
Moss, SJ
Pangalos, MN
机构
[1] GlaxoSmithKline, Dept Neurol CEDD, Harlow CM19 5AW, Essex, England
[2] GlaxoSmithKline, Dept Psychiat CEDD, Harlow CM19 5AW, Essex, England
[3] GlaxoSmithKline, Bioinformat Res Grp, Harlow CM19 5AW, Essex, England
[4] UCL, Dept Pharmacol, London WC1E 6BT, England
[5] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England
关键词
GABA(B); GPCR; dimerization; signaling; G-protein coupling; receptor subunits;
D O I
10.1523/JNEUROSCI.21-20-08043.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
GABA(B) receptors are unique among G-protein-coupled receptors (GPCRs) in their requirement for heterodimerization between two homologous subunits, GABA(B1) and GABA(B2), for functional expression. Whereas GABA(B1) is capable of binding receptor agonists and antagonists, the role of each GABA(B) subunit in receptor signaling is unknown. Here we identified amino acid residues within the second intracellular domain of GABA(B2) that are critical for the coupling of GABA(B) receptor heterodimers to their downstream effector systems. Our results provide strong evidence for a functional role of the GABA(B2) subunit in G-protein coupling of the GABA(B) receptor heterodimer. In addition, they provide evidence for a novel "sequential" GPCR signaling mechanism in which ligand binding to one heterodimer subunit can induce signal transduction through the second partner of a heteromeric complex.
引用
收藏
页码:8043 / 8052
页数:10
相关论文
共 39 条
[1]   AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration [J].
AbdAlla, S ;
Lother, H ;
Quitterer, U .
NATURE, 2000, 407 (6800) :94-98
[2]   ALSCRIPT - A TOOL TO FORMAT MULTIPLE SEQUENCE ALIGNMENTS [J].
BARTON, GJ .
PROTEIN ENGINEERING, 1993, 6 (01) :37-40
[3]   Nonlinear regression using spreadsheets [J].
Bowen, WP ;
Jerman, JC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (12) :413-417
[4]   GABA-B RECEPTOR PHARMACOLOGY [J].
BOWERY, NG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :109-147
[5]  
Calver AR, 2001, J NEUROSCI, V21, P1203
[6]   MUSCARINIC M-CURRENT INHIBITION VIA G(ALPHA-Q/11) AND ALPHA-ADRENOCEPTOR INHIBITION OF CA2+ CURRENT VIA G(ALPHA-O) IN RAT SYMPATHETIC NEURONS [J].
CAULFIELD, MP ;
JONES, S ;
VALLIS, Y ;
BUCKLEY, NJ ;
KIM, GD ;
MILLIGAN, G ;
BROWN, DA .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 477 (03) :415-422
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   GABAB receptor:: A new paradigm in G protein signaling [J].
Couve, A ;
Moss, SJ ;
Pangalos, MN .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2000, 16 (04) :296-312
[9]   Intracellular retention of recombinant GABAB receptors [J].
Couve, A ;
Filippov, AK ;
Connolly, CN ;
Bettler, B ;
Brown, DA ;
Moss, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26361-26367
[10]   Ab initio modeling and molecular dynamics simulation of the α1b-adrenergic receptor activation [J].
Fanelli, F ;
Menziani, C ;
Scheer, A ;
Cotecchia, S ;
De Benedetti, PG .
METHODS, 1998, 14 (03) :302-317